Meitav Dash Investments LTD Hepion Pharmaceuticals, Inc. Transaction History

Meitav Dash Investments LTD

  • $5.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021
SELL
$1.39 - $2.1 $69,500 - $105,000
-50,000 Closed
0 $0
Q2 2021

Aug 05, 2021
BUY
$1.56 - $2.26 $9,360 - $13,559
6,000 Added 13.64%
50,000 $99,000
Q1 2021

May 06, 2021
BUY
$1.77 - $2.98 $77,880 - $131,120
44,000 New
44,000 $81,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $51.8M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email